Archive for the ‘research’ Category

FREE Webinar: The State of Lyme Disease Research & Tick-Borne Disease-Related Legislative Action

https://us02web.zoom.us/webinar/register/WN_S4YmYqBvTECf6M5FyHkzMg#/registration  Register Here

The State of Lyme Disease Research and Tick-Borne Disease-Related Legislative Action

Date & Time
Nov 30, 2023 06:00 PM in Central Time (US and Canada)
Description
Join us Thursday, November 30 at 7 PM ET for an update on the State of Lyme Disease Research.
Description:
Bonnie Crater and Nicole Bell with the Center for Lyme Action will present an overview of their recently released policy paper – “The State of Lyme Disease Research in the United States.” The research paper explores the progress that has been made to find a cure for Lyme and tick-borne diseases, making 26 recommendations for research investments by the federal government and calling for an annual investment of $500 million – $1 billion to find a cure. The plan outlines five areas of opportunity in tick-borne disease research, including improving fundamental knowledge, detection, prevention, treatment, and research tools and resources.
This webinar is free to members and non-members.

Conclusive Evidence of mRNA “Vaccine” Shedding

https://www.lifesitenews.com/news/frontline-covid-doctor-says-there-is-now-conclusive-evidence-of-mrna-vaccine-shedding/

(LifeSiteNews) — According to a well-known leader in COVID-19 early medical treatments, “conclusive evidence” has been established that “clinically significant shedding” of the mRNA vaccines from the injected to the non-injected is indeed a reality.

Dr. Pierre Kory, who helped pioneer and tenaciously defend the use of “miraculous” ivermectin to treat COVID-19, has published an eight-part series on the question of “shedding,” a medical phenomenon which is defined by the Food and Drug Administration as:

The release of viral or bacterial gene therapy products from the patient by any or all of the following routes: feces (feces); secretions (urine, saliva, nasopharyngeal fluids, etc.); or through the skin (pustules, lesions, sores).

The Wisconsin-based physician, with a specialty in critical care, added the FDA “forgot to mention ‘exhaled breath’” to this list of possible means for transfer of the vaccine substance.

His latest article in the series relates 32 examples of unedited correspondence he has received from some of his 70,000 Substack readers describing “prior episodes of sudden-onset vaccine side effect symptoms after an exposure to vaccinated people.”  (See link for article and eight part series)

______________

For more:

Full Body Numbness & Tingling Due to Lyme Disease

https://danielcameronmd.com/full-body-numbness-and-tingling-due-to-lyme-disease/

FULL BODY NUMBNESS AND TINGLING DUE TO LYME DISEASE

numbness-lyme-disease

In their article “Lyme Disease Presenting With Interesting Neurological Features of Weakness and Hyporeflexia: A Case Report,” Semy and colleagues describe the unique case of a young woman with Lyme disease who exhibited solely neurologic features of numbness and tingling throughout her body. [1]

The 25-year-old female developed numbness and tingling throughout her torso, which later spread to her entire body. She presented to a neurology clinic with complaints of numbness and tingling that had been ongoing for the past 4 weeks.

She did not recall a rash or tick bite and had not recently travelled.

The woman did not exhibit any of the typical symptoms seen with Lyme disease such as “arthralgia, fever, rash, or regional lymphadenopathy but in fact exhibited decreased reflexes, numbness, and tingling particularly near the hypogastric region making it distinct from the classical presentation,” the authors wrote.

The numbness and tingling began on the right side of her stomach and radiated to her back and later spread to her entire body. “The tingling was not associated with any burning or pins and needle sensation,” the authors point out.

The woman was prescribed steroids and an albuterol inhaler. But her symptoms did not improve.

“She especially became alarmed when she could not hold her toddler anymore and ended up dropping the child secondary to her numbness and tingling.”

Motor examination revealed that the patient had “decreased tone more significant in the upper limbs (3/5) than in the lower limbs (4/5) along with hyporeflexia in the biceps, triceps, patellar, and Achilles,” the authors wrote.

A lumbar puncture revealed elevated protein concentration (148 mg/dl; normal: 15-60 mg/dl).

The Western blot test for Lyme disease was positive, and the woman was prescribed IV ceftriaxone for 3 days before transitioning to oral doxycycline.

“At the time of discharge, the patient was able to move all extremities spontaneously and ambulate with a normal gait,” the authors wrote. At her follow-up visit, she exhibited only minimal residuary weakness.

Authors’ Conclude:

  • “Physicians need to be aware of the non-pathognomonic timeline of the disease at presentation since the clinical presentation of the disease can differ significantly from one individual to another.”
References:
  1. Semy M, Lee-Kwen P, Semy S (August 10, 2023) Lyme Disease Presenting With Interesting Neurological Features of Weakness and Hyporeflexia: A Case Report. Cureus 15(8): e43296. doi:10.7759/cureus.43296

_______________

**Comment**

This woman needs long-term follow-up.  I wouldn’t be shocked at all if these symptoms came roaring back, which of course would necessitate treatment that our corrupt government states is “dangerous,” even though the alternative is deadly.

For more:

Pine Bark Extract Puts Aspirin to Shame

https://greenmedinfo.com/blog/powerful-aspirin-alternative-grows-trees-2

The Powerful Aspirin Alternative Your Doctor Never Told You About

Article Excerpts:

Pine Bark Extract (Pycnogenol) Puts Aspirin To Shame

When it comes to aspirin alternatives, one promising contender is pycnogenol, a powerful antioxidant extracted from French maritime pine bark, backed by over 40 years of research, the most compelling of which we have aggregated on GreenMedInfo.com here: Pycnogenol Research. Amazingly, you will find research indexed there showing it may have value for over 80 health conditions

Not Just A Drug Alternative

Pycnogenol, like so many other natural interventions, has a wide range of side benefits that may confer significant advantage when it comes to reducing cardiovascular disease risk. For instance, pycnogenol is also:

  • Blood Pressure Reducing/Endothelial Function Enhancer: A number of clinical studies indicate that pycnogenol is therapeutic for those suffering with hypertension. Pycnogenol actually addresses a root cause of hypertension and cardiovascular disease in general, namely, endothelial dysfunction (the inability of the inner lining of the blood vessels to function correctly, e.g. fully dilate).[1] It has been shown to prevent damage in microcirculation in hypertensive patients, as well as reducing the dose of blood pressure drugs in hypertensive patients,[2] including hypertensive diabetic patients.[3] It has even been found to reduce intraocular hypertension found in glaucoma patients.[4]
  • Anti-Inflammatory Effects: There is a growing appreciation among the medical community that inflammation contributes to cardiovascular disease. Several markers, including C-reactive protein are now being fore grounded as being at least as important in determining cardiovascular disease risk as various blood lipids and/or their ratios, such as low-density lipoprotein (LDL). Pycnogenol has been found to reduce C-reactive protein in hypertensive patients.[5] Pycnogenol has been found to rapidly modulate downward (inhibit) both Cox-1 and Cox-2 enzyme activity in human subjects, resulting in reduced expression of these inflammation-promoting enzymes within 30 minutes post-ingestion.[6] Another observed anti-inflammatory effect of pycnogenol is its ability to down-regulate the class of inflammatory enzymes known as matrix metalloproteinases (MMPs).[7] Pycnogenol has also been found to significantly inhibit NF-kappaB activation, a key body-wide regulator of inflammation levels whose overexpression and/or dysregulation may result in pathologic cardiovascular manifestations.[8] Finally, pycnogenol has been found to reduce fibrinogen levels, a glycoprotein that contributes to the formation of blood clots; fibrinogen has been identified as an independent risk factor for cardiovascular disease.[9]
  • The Ideal Air Travel Companion: In a previous article entitled, “How Pine Bark Extract Could Save Air Travelers Lives,” we delve into a compelling body of research that indicates pycnogenol may be the perfect preventive remedy for preventing flight-associated thrombosis, edema, and concerns related to radiotoxicity and immune suppression. 

For more:

  • Pycnogenol reduces pain & stiffness & improves physical function in knee osteoarthritis
  • Pycnogenol accelerates wound healing & reduces scar formation
  • Pycnogenol improves:
    • painful and visible symptoms of psoriasis
    • cognitive performance and neurodegeneration in the rat model
    • blood pressure
    • blood glucose
    • airway inflammation
    • pulmonary function
    • endometriosis
    • ADHD and hyperactivity
    • circulation
    • allergies
    • tinnitus
    • diabetes
    • ED
    • varicose veins
    • menopause symptoms

For more:

What Might Sudden Cardiac Death Due To Lyme Disease Look Like?

https://danielcameronmd.com/autopsy-study-reviews-cases-due-to-sudden-cardiac-death-from-lyme-disease/

WHAT MIGHT SUDDEN CARDIAC DEATH DUE TO LYME DISEASE LOOK LIKE?

What might sudden cardiac death due to Lyme disease look like?

“Although rare, sudden cardiac death caused by Lyme disease might be an under-recognized entity,” according to researchers who describe their findings from an autopsy study on 5 case patients who died from sudden cardiac death and were found post mortem to have Lyme carditis. The cases are discussed in an article entitled Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis, published in The American Journal of Pathology.

Fatal Lyme carditis is rarely identified. In reviewing five post mortem cases, Muehlenbach and colleagues found that Lyme disease was not suspected for one patient who complained of episodic shortness of breath, while the second patient tested negative for Lyme disease. Two other patients did not seek medical care. Details regarding the fifth patient were not released.

Ultimately, two case patients were diagnosed during unexplained-death investigations at the Centers for Disease Control and Prevention (CDC). Lyme disease was suspected in two of the other cases by cardiac pathology at a tissue bank transplant service. Muehlenbachs and colleagues reassure the readers that cardiac tissue was not transplanted. [1]

Autopsies reveal several findings

Spirochetes were present in the heart on all 5 cases. When using immunohistochemistry (IHC), spirochetes were found “within the myocardial interstitial infiltrates, in the subendocardium, and occasionally in pericardial tissue in association with lymphohistiocytic infiltrates.” Muehlenbachs adds, “Rare spirochetes were seen in the leptomeninges of two cases by immunohistochemistry.”

All 5 cases lived in Lyme-endemic areas. Patients resided in counties with a high or moderate incidence of Lyme disease including, New York, New Hampshire (with recent travel to Connecticut), Massachusetts and Indiana.

All 5 cases reportedly engaged in outdoor activities. “Two patients had known exposure to ticks, and one patient reported a recent bite.”

None of the 5 cases met the CDC surveillance case definition for Lyme carditis. This definition includes: recurrent, brief attacks (weeks or months) of objective joint swelling in one or several joints; lymphocytic meningitis; cranial neuritis; radiculoneuropathy; encephalomyelitis; acute onset of high-grade (2nd-degree or 3rd-degree) atrioventricular conduction defects, and myocarditis.

Only 1 of the 5 cases underwent serologic screening for Lyme disease and the results were negative.

All 5 cases were symptomatic prior to their death. “A prodrome was reported for each of the patients that included the following: non-specific viral-like illness, malaise, shortness of breath, and anxiety,” according to Muehlenbachs. “One of these patients also had joint and muscle pain, and the other two patients had joint pain for an unknown duration.”

No dermatologic lesion was documented or reported for any of the patients, although one patient was evaluated in an emergency department 1 month before death for an arm lesion diagnosed as a possible spider bite from which methicillin-resistant Staphylococcus aureus was isolated in culture.”

“Providers should consider Lyme disease in patients who have cardiac symptoms and exposure in an endemic area.” [1]

All 5 cases were seropositive post mortem according to the CDC’s two-tier criteria. “One sample met both IgM and IgG Western Blot (WB) criteria, with two of the three IgM bands and 6 of the 10 IgG bands reactive. The four remaining samples were positive by IgM WB criteria only, although three were nearly IgG positive with 4 of the 10 bands reactive,” states Muehlenbachs.

Underlying cardiac disease may have played a role in 3 of the 5 cases of sudden cardiac deaths associated with Lyme disease, Muehlenbachs points out, since there was significant underlying heart disease present in two patients, and an additional patient had moderate atherosclerosis, discovered at autopsy.

Physiological cardiac stress was considered a potential factor in 2 of the 5 cases. “In the other two patients, who were otherwise healthy, a degree of physiological cardiac stress likely was present: the woman had given birth 6 months previously and the man was a physically active outdoor enthusiast,” according to Muehlenbachs.

These pathologic findings provide insight into the possible cause behind sudden cardiac deaths associated with Lyme disease. “The findings support the proposed disease mechanism of spirochete cardiac tropism during early disease dissemination, the infiltration of cardiac tissue by inflammatory cells, and involvement of the conduction system, which likely mediates sudden cardiac death.” [1]

Is early diagnosis and prompt treatment possible?

“Early diagnosis and prompt treatment for Lyme carditis can be life-saving,” according to Muehlenbachs. “Health care professionals should evaluate all patients with suspected Lyme disease for cardiac signs and symptoms, and obtain an electrocardiogram promptly if carditis is suspected.” Furthermore, “diagnosis is based on clinical suspicion and serologic testing, with the caveat that serology testing may be falsely negative in a patient with recent illness onset.” [1]

Fishe and colleagues describe how early diagnosis and treatment helped save the life of a 15-year-old African-American girl with Lyme carditis. [2] The patient was hospitalized after a 3-day history of intermittent retrosternal and epigastric pain. After treatment was initiated, she developed a heart block. Tests for Lyme disease were positive and she was diagnosed with Lyme disease-associated myocarditis.

The adolescent was empirically started on doxycycline and was concurrently treated with milrinone infusion for afterload reduction and intravenous furosemide for pulmonary edema. Her EKG changed to first-degree heart block by day 2 and resolved completely on hospital day 3.

She recovered and was discharged home on hospital day 7 on oral furosemide, enalapril, and doxycycline, according to Fishe and colleagues.

However, another adolescent was not so fortunate. He died suddenly from undiagnosed Lyme carditis, following complaints of flu-like symptoms. The case is discussed in another All Things Lyme blog, Relying on a Negative Lyme Disease Test Can Prove Deadly.

“In patients with Lyme disease who complain of cardiopulmonary symptoms, clinicians should have a low threshold for obtaining an EKG to evaluate for Lyme carditis,” Fishe points out. Furthermore, clinicians should take note that in “children and adolescents, respiratory and gastrointestinal complaints, with or without chest pain, are the most frequent presenting symptoms.”

References:

  1. Muehlenbachs A, Bollweg BC, Schulz TJ et al. Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis. Am J Pathol, (2016).
  2. Fishe JN, Marchese RF, Callahan JM. Lyme Myocarditis Presenting as Chest Pain in an Adolescent Girl. Pediatr Emerg Care, (2016).